Mutations in isocitrate dehydrogenase 2 accelerate glioma cell migration via matrix metalloproteinase-2 and 9

Glioma-derived mutations in isocitrate dehydrogenase 2 beneficial to traditional chemotherapy

(2011) Yuejun Fu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

A model of BmK CT in inhibiting glioma cell migration via matrix metalloproteinase-2 from experimental and molecular dynamics simulation study

(2011) Yue-Jun Fu et al.   BIOTECHNOLOGY LETTERS

Metalloproteinases in metabolic syndrome

(2011) Gabriela Berg et al.   CLINICA CHIMICA ACTA

Expression of Matrix Metalloproteinases and Their Inhibitors in Squamous Cell Carcinoma of the Tonsil and Their Clinical Significance

(2011) Sei Young Lee et al.   Clinical and Experimental Otorhinolaryngology

Inhibitory effects of GL-V9 on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-2/9

(2011) Liwen Li et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Prognostic impact of MMP-2 and MMP-9 expression in pathologic stage IA non-small cell lung cancer

(2011) Wenlong Shao et al.   JOURNAL OF SURGICAL ONCOLOGY

Matrix metalloproteinase inhibitor properties of tetracyclines: Therapeutic potential in cardiovascular diseases

(2011) Michele M. Castro et al.   PHARMACOLOGICAL RESEARCH

MMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells

(2011) Aruna Venkata Badiga et al.   PLoS One

Glioma-derived mutations in IDH: From mechanism to potential therapy

(2010) Yuejun Fu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

α-Catenin inhibits glioma cell migration, invasion, and proliferation by suppression of β-catenin transactivation

(2010) Haitao Ji et al.   JOURNAL OF NEURO-ONCOLOGY

Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1 

(2009) S. Zhao et al.   SCIENCE